These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| ☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
20-5338862
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer
Identification No.) |
|
|
1 HaMada Street
Herziliya Pituach 4673335, Israel (Address of principal executive offices, zip code) |
||
|
972 (9) 957-6620
|
||
|
(Registrant’s telephone number, including area code)
|
|
Large accelerated filer
|
☒
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☐ (Do not check if a smaller reporting company)
|
Smaller Reporting Company
|
☐
|
|
Emerging growth company
|
☐
|
|
3
|
||
|
3
|
||
| F-2 | ||
| F-4 | ||
| F-5 | ||
| F-6 | ||
| F-8 | ||
|
4
|
||
|
16
|
||
|
17
|
||
|
17
|
||
|
17
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
18
|
||
|
19
|
||
|
19
|
||
|
Page
|
|
|
F-2 - F-3
|
|
|
F-4
|
|
|
F-5
|
|
|
F-6 - F-7
|
|
|
F-8 - F-27
|
|
June 30,
|
December 31,
|
|||||||
|
2018
|
2017
|
|||||||
|
Unaudited
|
||||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
214,540
|
$
|
163,163
|
||||
|
Restricted cash
|
2,049
|
1,516
|
||||||
|
Marketable Securities
|
134,821
|
77,264
|
||||||
|
Trade receivables, net
|
118,103
|
109,528
|
||||||
|
Prepaid expenses and other accounts receivable
|
44,520
|
42,223
|
||||||
|
Inventories
|
102,014
|
82,992
|
||||||
|
Total
current assets
|
616,047
|
476,686
|
||||||
|
LONG-TERM ASSETS:
|
||||||||
|
Marketable securities
|
$
|
86,144
|
$
|
103,120
|
||||
|
Property, equipment and intangible assets, net
|
68,532
|
52,297
|
||||||
|
Prepaid expenses and lease deposits
|
956
|
862
|
||||||
|
Deferred tax assets, net
|
11,551
|
8,340
|
||||||
|
Total
long term assets
|
167,183
|
164,619
|
||||||
|
Total
assets
|
$
|
783,230
|
$
|
641,305
|
||||
|
June 30,
|
December 31,
|
|||||||
|
2018
|
2017
|
|||||||
|
Unaudited
|
||||||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Trade payables, net
|
$
|
81,610
|
$
|
69,488
|
||||
|
Employees and payroll accruals
|
23,510
|
22,544
|
||||||
|
Warranty obligations
|
18,964
|
14,785
|
||||||
|
Deferred revenues
|
3,407
|
2,559
|
||||||
|
Accrued expenses and other accounts payable
|
26,480
|
20,378
|
||||||
|
Total
current liabilities
|
153,971
|
129,754
|
||||||
|
LONG-TERM LIABILITIES:
|
||||||||
|
Warranty obligations
|
78,327
|
64,026
|
||||||
|
Deferred revenues
|
47,595
|
31,453
|
||||||
|
Lease incentive obligation
|
1,616
|
1,765
|
||||||
|
Non-current tax liabilities
|
16,830
|
16,840
|
||||||
|
Total
long-term liabilities
|
144,368
|
114,084
|
||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
STOCKHOLDERS’ EQUITY:
|
||||||||
|
Common stock of $0.0001 par value - Authorized: 125,000,000 shares as of June 30, 2018 (unaudited) and December 31, 2017; issued and outstanding: 45,498,414 and 43,812,601 shares as of June 30, 2018 (unaudited) and December 31, 2017, respectively
|
5
|
4
|
||||||
|
Additional paid-in capital
|
353,470
|
331,902
|
||||||
|
Accumulated other comprehensive loss
|
(1,138
|
)
|
(611
|
)
|
||||
|
Retained earnings
|
132,554
|
66,172
|
||||||
|
Total
stockholders’ equity
|
484,891
|
397,467
|
||||||
|
Total
liabilities and stockholders’ equity
|
$
|
783,230
|
$
|
641,305
|
||||
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
Unaudited
|
Unaudited
|
|||||||||||||||
|
Revenues
|
$
|
227,118
|
$
|
136,099
|
$
|
436,989
|
$
|
251,153
|
||||||||
|
Cost of revenues
|
145,172
|
89,033
|
275,446
|
165,411
|
||||||||||||
|
Gross profit
|
81,946
|
47,066
|
161,543
|
85,742
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
19,551
|
12,725
|
37,426
|
24,183
|
||||||||||||
|
Sales and marketing
|
15,954
|
11,961
|
32,159
|
22,736
|
||||||||||||
|
General and administrative
|
5,776
|
3,265
|
10,465
|
7,704
|
||||||||||||
|
Total
operating expenses
|
41,281
|
27,951
|
80,050
|
54,623
|
||||||||||||
|
Operating income
|
40,665
|
19,115
|
81,493
|
31,119
|
||||||||||||
|
Financial income (expenses), net
|
(2,480
|
)
|
3,595
|
(1,896
|
)
|
5,005
|
||||||||||
|
Other expenses
|
-
|
-
|
64
|
-
|
||||||||||||
|
Income before taxes on income
|
38,185
|
22,710
|
79,533
|
36,124
|
||||||||||||
|
Taxes on income (tax benefit)
|
3,617
|
186
|
9,279
|
(575
|
)
|
|||||||||||
|
Net income
|
$
|
34,568
|
$
|
22,524
|
$
|
70,254
|
$
|
36,699
|
||||||||
|
Net basic earnings per share of common stock
|
$
|
0.76
|
$
|
0.54
|
$
|
1.57
|
$
|
0.88
|
||||||||
|
Net diluted earnings per share of common stock
|
$
|
0.72
|
$
|
0.50
|
$
|
1.46
|
$
|
0.83
|
||||||||
|
Weighted average number of shares used in computing net basic earnings per share of common stock
|
45,216,253
|
41,700,399
|
44,726,382
|
41,525,285
|
||||||||||||
|
Weighted average number of shares used in computing net diluted earnings per share of common stock
|
48,291,280
|
44,831,590
|
47,984,817
|
44,335,521
|
||||||||||||
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
Unaudited
|
Unaudited
|
|||||||||||||||
|
Net income
|
$
|
34,568
|
$
|
22,524
|
$
|
70,254
|
$
|
36,699
|
||||||||
|
Other comprehensive income (loss):
|
||||||||||||||||
|
Available-for-sale securities:
|
||||||||||||||||
|
Changes in unrealized gains (losses) net of tax expenses (benefit)
|
(6
|
)
|
5
|
(516
|
)
|
33
|
||||||||||
|
Net change
|
(6
|
)
|
5
|
(516
|
)
|
33
|
||||||||||
|
Cash flow hedges:
|
||||||||||||||||
|
Changes in unrealized gains, net of tax expense
|
-
|
66
|
-
|
975
|
||||||||||||
|
Reclassification adjustments for loses, net of tax expense included in net income
|
-
|
(599
|
)
|
-
|
(994
|
)
|
||||||||||
|
Net change
|
-
|
(533
|
)
|
-
|
(19
|
)
|
||||||||||
|
Foreign currency translation adjustments, net
|
3
|
186
|
(11
|
)
|
(57
|
)
|
||||||||||
|
Total other comprehensive loss
|
(3
|
)
|
(342
|
)
|
(527
|
)
|
(43
|
)
|
||||||||
|
Comprehensive income
|
$
|
34,565
|
$
|
22,182
|
$
|
69,727
|
$
|
36,656
|
||||||||
|
Six months ended
June 30,
|
||||||||
|
2018
|
2017
|
|||||||
|
Unaudited
|
||||||||
|
Cash flows provided by operating activities:
|
||||||||
|
Net income
|
$
|
70,254
|
$
|
36,699
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization of property, equipment and intangible assets
|
5,053
|
3,130
|
||||||
|
Amortization of premiums on available-for-sale marketable securities
|
1,014
|
791
|
||||||
|
Stock-based compensation
|
13,977
|
7,646
|
||||||
|
Deferred tax assets, net
|
(3,018
|
)
|
(2,105
|
)
|
||||
|
Loss on disposals of fixed assets
|
64
|
-
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Inventories
|
(18,952
|
)
|
11,153
|
|||||
|
Prepaid expenses and other accounts receivable
|
(2,135
|
)
|
(12,675
|
)
|
||||
|
Trade receivables, net
|
(9,203
|
)
|
(8,399
|
)
|
||||
|
Trade payables, net
|
12,143
|
2,007
|
||||||
|
Employees and payroll accruals
|
1,028
|
1,206
|
||||||
|
Warranty obligations
|
18,479
|
6,965
|
||||||
|
Deferred revenues
|
13,120
|
6,935
|
||||||
|
Accrued expenses and other accounts payable
|
6,194
|
3,958
|
||||||
|
Lease incentive obligation
|
(148
|
)
|
(148
|
)
|
||||
|
Net cash provided by operating activities
|
107,870
|
57,163
|
||||||
|
Cash flows used in investing activities:
|
||||||||
|
Purchase of property and equipment
|
(21,385
|
)
|
(7,611
|
)
|
||||
|
Investment in available-for-sale marketable securities
|
(89,389
|
)
|
(74,106
|
)
|
||||
|
Maturities of available-for-sale marketable securities
|
46,825
|
31,674
|
||||||
|
Net cash used in investing activities
|
(63,949
|
)
|
(50,043
|
)
|
||||
|
Six months ended
June 30,
|
||||||||
|
2018
|
2017
|
|||||||
|
Unaudited
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from issuance of shares under stock purchase plan and upon exercise of stock-based awards
|
7,591
|
2,123
|
||||||
|
Net cash provided by financing activities
|
7,591
|
2,123
|
||||||
|
Net increase in cash, cash equivalents and restricted cash
|
51,512
|
9,243
|
||||||
|
Cash, cash equivalents and restricted cash at the beginning of the period
|
164,679
|
105,580
|
||||||
|
Effect of exchange rate differences on cash, cash equivalents and restricted cash
|
398
|
(274
|
)
|
|||||
|
Cash, cash equivalents and restricted cash at the end of the period
|
$
|
216,589
|
$
|
114,549
|
||||
| NOTE 1:- |
GENERAL
|
| a. |
SolarEdge Technologies, Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution designed to maximize power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features
.
The Company’s products consist mainly of (i) power optimizers designed to maximize energy throughput from each and every module through constant tracking of Maximum Power Point individually per module, (ii) inverters which invert direct current (DC) from the PV module to alternating current (AC) and (iii) a related cloud-based monitoring platform, that collects and processes information from the power optimizers and inverters of a solar PV system to enable customers and system owners as applicable, to monitor and manage the solar PV systems. In addition, the Company has a storage solution that is used to increase energy independence and maximize self-consumption for homeowners by utilizing a battery that is sold separately by third party manufacturers, to store and supply power as needed (the “StorEdge solution”). The StorEdge solution is designed to provide smart energy functions such as maximizing self-consumption, Time-of-Use programming for desired hours of the day, and home energy backup solutions.
|
| b. |
New accounting pronouncements not yet effective:
|
| NOTE 1:- |
GENERAL (Cont.)
|
| c. |
Recently issued and adopted pronouncements:
|
| (1) |
Identify the contract with a customer
|
| NOTE 1:- |
GENERAL (Cont.)
|
| (2) |
Identify the performance obligations in the contract
|
| (3) |
Determine the transaction price
|
| (4) |
Allocate the transaction price to the performance obligations in the contract
|
| NOTE 1:- |
GENERAL (Cont.)
|
| (5) |
Recognize revenue when a performance obligation is satisfied
|
|
Balance as of December 31, 2017
|
Adjustments due following adoption of ASC 606
|
Balance as of January 1, 2018
|
||||||||||
|
Unaudited
|
Unaudited
|
|||||||||||
|
Deferred Revenues - Current term
|
$
|
2,559
|
$
|
(89
|
)
|
$
|
2,470
|
|||||
|
Deferred Revenues - Long term
|
31,453
|
3,961
|
35,414
|
|||||||||
|
Retained earnings
|
$
|
66,172
|
$
|
(3,872
|
)
|
$
|
62,300
|
|||||
| NOTE 1:- |
GENERAL (Cont.)
|
|
Three months ended June 30, 2018 (Unaudited)
|
||||||||||||
|
As Reported
|
Balances before adoption of ASC 606
|
Effect of change
|
||||||||||
|
Statements of operations
|
||||||||||||
|
Revenues
|
$
|
227,118
|
$
|
227,067
|
$
|
51
|
||||||
|
Financial income (expenses), net
|
(2,480
|
)
|
(1,913
|
)
|
(567
|
)
|
||||||
|
Net income
|
34,568
|
35,084
|
(516
|
)
|
||||||||
|
Cash flows
|
||||||||||||
|
Net income
|
34,568
|
35,084
|
(516
|
)
|
||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Deferred revenues
|
6,139
|
5,623
|
516
|
|||||||||
|
Six months ended June 30, 2018 (Unaudited)
|
||||||||||||
|
As Reported
|
Balances before adoption of ASC 606
|
Effect of change
|
||||||||||
|
Statements of operations
|
||||||||||||
|
Revenues
|
$
|
436,989
|
$
|
436,
938
|
$
|
51
|
||||||
|
Financial income (expenses), net
|
(1,896
|
)
|
(817
|
)
|
(1,079
|
)
|
||||||
|
Net income
|
70,254
|
71,282
|
(1,028
|
)
|
||||||||
|
Cash flows
|
||||||||||||
|
Net income
|
70,254
|
71,282
|
(1,028
|
)
|
||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Deferred revenues
|
13,120
|
12,092
|
1,028
|
|||||||||
|
Balance Sheets
|
||||||||||||
|
Deferred Revenues - Current
|
(3,407
|
)
|
(3,413
|
)
|
6
|
|||||||
|
Deferred Revenues - Long term
|
(47,595
|
)
|
(42,689
|
)
|
(4,906
|
)
|
||||||
|
Retained earnings
|
$
|
(132,554
|
)
|
$
|
(136,426
|
)
|
$
|
3,872
|
||||
| NOTE 1:- |
GENERAL (Cont.)
|
| d. |
Basis of Presentation:
|
| e. |
The Company depends on three contract manufacturers and several limited or single source component suppliers. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs
.
|
| f. |
Derivative financial instruments:
|
| NOTE 1:- |
GENERAL (Cont.)
|
|
Balance as of June 30,
|
Balance as of December 31,
|
|||||||
|
2018
|
2017
|
|||||||
|
(unaudited)
|
||||||||
|
Derivative assets:
|
||||||||
|
Derivatives not designated as cash flow hedging instruments:
|
||||||||
|
Foreign exchange option contracts
|
$
|
340
|
$
|
221
|
||||
|
Foreign exchange forward contracts
|
312
|
-
|
||||||
|
Total
|
$
|
652
|
$
|
221
|
||||
|
Derivative liabilities:
|
||||||||
|
Derivatives not designated as cash flow hedging instruments:
|
||||||||
|
Foreign exchange option contracts
|
$
|
(24
|
)
|
$
|
(285
|
)
|
||
|
Foreign exchange forward contracts
|
-
|
(116
|
)
|
|||||
|
Total
|
$
|
(24
|
)
|
$
|
(401
|
)
|
||
|
Three months ended
|
Six months ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
(unaudited)
|
(unaudited)
|
|||||||||||||||
|
Derivatives designated as cash flow hedging instruments:
|
||||||||||||||||
|
Foreign exchange forward contracts
|
-
|
$
|
66
|
-
|
$
|
975
|
||||||||||
| NOTE 1:- |
GENERAL (Cont.)
|
|
Three months ended
|
Six months ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
(unaudited)
|
(unaudited)
|
|||||||||||||||
|
Derivatives designated as cash flow hedging instruments:
|
||||||||||||||||
|
Foreign exchange forward contracts
|
-
|
$
|
(599
|
)
|
-
|
$
|
(994
|
)
|
||||||||
| g. |
Accumulated other comprehensive income:
|
|
Unrealized gains (losses) on available-for-sale marketable securities
|
Unrealized gains (losses) on foreign currency translation
|
Total
|
||||||||||
|
Beginning balance
|
$
|
(943
|
)
|
$
|
(192
|
)
|
$
|
(1,135
|
)
|
|||
|
Net other comprehensive income (loss) before reclassifications
|
(6
|
)
|
3
|
(3
|
)
|
|||||||
|
Net current period other comprehensive income (loss)
|
(6
|
)
|
3
|
(3
|
)
|
|||||||
|
Ending balance
|
$
|
(949
|
)
|
$
|
(189
|
)
|
$
|
(1,138
|
)
|
|||
|
Unrealized losses on available-for-sale marketable securities
|
Unrealized losses on foreign currency translation
|
Total
|
||||||||||
|
Beginning balance
|
$
|
(433
|
)
|
$
|
(178
|
)
|
$
|
(611
|
)
|
|||
|
Net other comprehensive loss before reclassifications
|
(516
|
)
|
(11
|
)
|
(527
|
)
|
||||||
|
Net current period other comprehensive loss
|
(516
|
)
|
(11
|
)
|
(527
|
)
|
||||||
|
Ending balance
|
$
|
(949
|
)
|
$
|
(189
|
)
|
$
|
(1,138
|
)
|
|||
| NOTE 1:- |
GENERAL (Cont.)
|
|
Unrealized gains (losses) on available-for-sale marketable securities
|
Unrealized gains (losses) on cash flow hedges
|
Unrealized gains (losses) on foreign currency translation
|
Total
|
|||||||||||||
|
Beginning balance
|
$
|
(108
|
)
|
$
|
533
|
$
|
(450
|
)
|
$
|
(25
|
)
|
|||||
|
Net other comprehensive income before reclassifications
|
5
|
66
|
186
|
257
|
||||||||||||
|
Net gains reclassified from accumulated other comprehensive loss
|
-
|
(599
|
)
|
-
|
(599
|
)
|
||||||||||
|
Net current period other comprehensive income (loss)
|
5
|
(533
|
)
|
186
|
(342
|
)
|
||||||||||
|
Ending balance
|
$
|
(103
|
)
|
$
|
-
|
$
|
(264
|
)
|
$
|
(367
|
)
|
|||||
|
Unrealized gains (losses) on available-for-sale marketable securities
|
Unrealized gains (losses) on cash flow hedges
|
Unrealized gains (losses) on foreign currency translation
|
Total
|
|||||||||||||
|
Beginning balance
|
$
|
(136
|
)
|
$
|
19
|
$
|
(207
|
)
|
$
|
324
|
||||||
|
Net other comprehensive income (loss) before reclassifications
|
33
|
975
|
(57
|
)
|
951
|
|||||||||||
|
Net gains reclassified from accumulated other comprehensive income (loss)
|
-
|
(994
|
)
|
-
|
(994
|
)
|
||||||||||
|
Net current period other comprehensive income (loss)
|
33
|
(19
|
)
|
(57
|
)
|
(43
|
)
|
|||||||||
|
Ending balance
|
$
|
(103
|
)
|
$
|
-
|
$
|
(264
|
)
|
$
|
(367
|
)
|
|||||
| NOTE 1:- |
GENERAL (Cont.)
|
|
Details about Accumulated
Other Comprehensive Loss Components
|
Amount Reclassified from Accumulated Other Comprehensive Loss
|
Affected Line Item in the Statements of Income
|
|||||||
|
Three months ended
June 30,
|
|||||||||
|
2018
|
2017
|
||||||||
|
Unrealized gains on cash flow hedges, net
|
$
|
-
|
$
|
108
|
Cost of revenues
|
||||
|
-
|
363
|
Research and development
|
|||||||
|
-
|
92
|
Sales and marketing
|
|||||||
|
-
|
82
|
General and administrative
|
|||||||
|
-
|
645
|
Total, before income taxes
|
|||||||
|
-
|
(46
|
)
|
Income tax expense (benefit)
|
||||||
|
$
|
-
|
$
|
599
|
Total, net of income taxes
|
|||||
|
Details about Accumulated
Other Comprehensive Loss Components
|
Amount Reclassified from Accumulated Other Comprehensive Loss
|
Affected Line Item in the Statements of Income
|
|||||||
|
Six months ended
June 30,
|
|||||||||
|
2018
|
2017
|
||||||||
|
Unrealized gains on cash flow hedges, net
|
$
|
-
|
$
|
166
|
Cost of revenues
|
||||
|
-
|
570
|
Research and development
|
|||||||
|
-
|
151
|
Sales and marketing
|
|||||||
|
-
|
153
|
General and administrative
|
|||||||
|
|
|||||||||
|
-
|
1,040
|
Total, before income taxes
|
|||||||
|
|
|||||||||
|
-
|
(46
|
)
|
Income tax expense (benefit)
|
||||||
|
|
|||||||||
|
$
|
-
|
$
|
994
|
Total, net of income taxes
|
|||||
| NOTE 2:- |
INVENTORIES
|
|
June 30,
2018
|
December 31,
2017
|
|||||||
|
(unaudited)
|
||||||||
|
Raw materials
|
$
|
28,842
|
$
|
25,887
|
||||
|
Finished goods
|
73,172
|
57,105
|
||||||
|
$
|
102,014
|
$
|
82,992
|
|||||
| NOTE 3:- |
WARRANTY OBLIGATIONS
|
|
Six months ended
June 30,
|
||||||||
|
2018
|
2017
|
|||||||
|
(unaudited)
|
||||||||
|
Balance, at beginning of period
|
$
|
78,811
|
$
|
58,375
|
||||
|
Additions and adjustments to cost of revenues
|
27,546
|
12,976
|
||||||
|
Utilization and current warranty expenses
|
(9,066
|
)
|
(6,011
|
)
|
||||
|
Balance, at end of period
|
97,291
|
65,340
|
||||||
|
Less current portion
|
(18,964
|
)
|
(12,501
|
)
|
||||
|
Long term portion
|
$
|
78,327
|
$
|
52,839
|
||||
| NOTE 4:- |
FAIR VALUE MEASUREMENTS
|
| Level 1- |
Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.
|
| Level 2- |
Include other inputs that are directly or indirectly observable in the marketplace.
|
| Level 3- |
Unobservable inputs which are supported by little or no market activity.
|
| NOTE 4:- |
FAIR VALUE MEASUREMENTS (Cont.)
|
|
|
Balance as of
|
Fair value measurements
|
||||||||||||||
|
Description
|
June 30,
2018
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
Cash equivalents:
|
||||||||||||||||
|
Money market mutual funds
|
$
|
6,641
|
$
|
6,641
|
-
|
-
|
||||||||||
|
Derivative instruments assets, net
|
$
|
628
|
-
|
$
|
628
|
-
|
||||||||||
|
Short-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
128,847
|
-
|
$
|
128,847
|
-
|
||||||||||
|
Governmental bonds
|
$
|
5,974
|
-
|
$
|
5,974
|
-
|
||||||||||
|
Long-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
80,208
|
-
|
$
|
80,208
|
-
|
||||||||||
|
Governmental bonds
|
$
|
5,936
|
-
|
$
|
5,936
|
-
|
||||||||||
|
|
Balance as of
|
Fair value measurements
|
||||||||||||||
|
Description
|
December 31,
2017
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||
|
Cash equivalents:
|
||||||||||||||||
|
Money market mutual funds
|
$
|
6,163
|
$
|
6,163
|
-
|
-
|
||||||||||
|
Derivative instruments liability, net
|
$
|
(180
|
)
|
-
|
$
|
(180
|
)
|
-
|
||||||||
|
Short-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
68,272
|
-
|
$
|
68,272
|
-
|
||||||||||
|
Governmental bonds
|
$
|
8,992
|
-
|
$
|
8,992
|
-
|
||||||||||
|
Long-term marketable securities:
|
||||||||||||||||
|
Corporate bonds
|
$
|
95,160
|
-
|
$
|
95,160
|
-
|
||||||||||
|
Governmental bonds
|
$
|
7,960
|
-
|
$
|
7,960
|
-
|
||||||||||
| NOTE 4:- |
FAIR VALUE MEASUREMENTS (Cont.)
|
| NOTE 5:- |
COMMITMENTS AND CONTINGENT LIABILITIES
|
| a. |
Guarantees:
|
| b. |
Contractual purchase obligations:
|
| c. |
Legal claims:
|
| NOTE 6:- |
STOCK CAPITAL
|
| a. |
Common Stock:
|
|
Authorized
|
Issued and outstanding
|
|||||||||||||||
|
Number of shares
|
||||||||||||||||
|
June 30,
2018
|
December 31,
2017
|
June 30,
2018
|
December 31,
2017
|
|||||||||||||
|
(unaudited)
|
(unaudited)
|
|||||||||||||||
|
Stock of $0.0001 par value:
|
||||||||||||||||
|
Common stock
|
125,000,000
|
125,000,000
|
45,498,414
|
43,812,601
|
||||||||||||
| b. |
Stock Incentive plans:
|
|
The Share Reserve will automatically increase on January 1st of each year during the term of the 2015 Plan commencing on January 1st of the year following the year in which the 2015 Plan becomes effective in an amount equal to five percent (5%) of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year; provided, however, that our board of directors may provide that there will not be a January 1st increase in the Share Reserve in a given year or that the increase will be less than five percent (5%) of the shares of capital stock outstanding on the preceding December 31st
.
|
| NOTE 6:- |
STOCK CAPITAL (Cont.)
|
| c. |
Options granted to employees
and members of the board of directors:
|
|
Weighted
|
||||||||||||||||
|
average
|
||||||||||||||||
|
Weighted
|
remaining
|
|||||||||||||||
|
Number
|
average
|
contractual
|
Aggregate
|
|||||||||||||
|
of
|
exercise
|
term
|
intrinsic
|
|||||||||||||
|
Options
|
price
|
in years
|
Value
|
|||||||||||||
|
Outstanding as of December 31, 2017
|
3,524,310
|
7.40
|
6.35
|
106,251
|
||||||||||||
|
Granted
|
180,983
|
38.05
|
||||||||||||||
|
Exercised
|
(1,219,007
|
)
|
4.86
|
|||||||||||||
|
Forfeited or expired
|
(22,677
|
)
|
8.46
|
|||||||||||||
|
Outstanding as of June 30, 2018
|
2,463,609
|
10.90
|
6.68
|
91,022
|
||||||||||||
|
Vested and expected to vest as of June 30, 2018
|
2,395,526
|
10.81
|
6.66
|
88,724
|
||||||||||||
|
Exercisable as of June 30, 2018
|
1,564,382
|
7.12
|
5.93
|
63,722
|
||||||||||||
| d. |
A summary of the activity in the RSUs granted to employees and members of the board of directors for the six months ended June 30
, 2018
(unaudited) is as follows:
|
|
No. of
RSUs
|
Weighted average
grant date
fair value
|
|||||||
|
Unvested as of December 31, 2017
|
2,087,992
|
24.33
|
||||||
|
Granted
|
531,729
|
48.15
|
||||||
|
Vested
|
(393,939
|
)
|
21.16
|
|||||
|
Forfeited
|
(125,989
|
)
|
6.62
|
|||||
|
Unvested as of
June 30, 2018
|
2,099,793
|
30.71
|
||||||
| NOTE 6:- |
STOCK CAPITAL (Cont.)
|
|
Outstanding
|
Exercisable
|
||||||||||||
|
as of
|
as of
|
||||||||||||
|
|
June 30,
|
Exercise
|
June 30,
|
Exercisable
|
|||||||||
|
Issuance Date
|
2018
|
price
|
2018
|
Through
|
|||||||||
|
January 27, 2014
|
225
|
3.51
|
31
|
January 27, 2024
|
|||||||||
|
May 1, 2014
|
1,205
|
3.51
|
1,205
|
May 1, 2024
|
|||||||||
|
September 17, 2014
|
3,936
|
3.96
|
3,831
|
September 17, 2024
|
|||||||||
|
October 29, 2014
|
2,139
|
5.01
|
361
|
October 29, 2024
|
|||||||||
|
August 19, 2015
|
6,981
|
0.00
|
-
|
-
|
|||||||||
|
November 8, 2015
|
928
|
0.00
|
-
|
- | |||||||||
|
April 18, 2016
|
834
|
0.00
|
-
|
- | |||||||||
|
July 11, 2016
|
1,167
|
0.00
|
-
|
- | |||||||||
|
September 21, 2016
|
2,500
|
15.34
|
250
|
September 21, 2026
|
|||||||||
|
September 21, 2016
|
3,938
|
0.00
|
-
|
- | |||||||||
|
March 15, 2017
|
6,000
|
0.00
|
-
|
- | |||||||||
|
March 15, 2017
|
6,500
|
13.70
|
500
|
March 15, 2027
|
|||||||||
|
March 27, 2017
|
3,000
|
0.00
|
-
|
-
|
|||||||||
|
November 20, 2017
|
5,250
|
0.00
|
-
|
- | |||||||||
|
January 2, 2018
|
6,160
|
0.00
|
-
|
- | |||||||||
|
50,763
|
6,178
|
||||||||||||
| f. |
Employee Stock Purchase Plan (“ESPP”):
|
| NOTE 6:- |
STOCK CAPITAL (Cont.)
|
| g. |
Stock-based compensation expense for employees and consultants:
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
Cost of revenues
|
$
|
968
|
$
|
517
|
$
|
1,892
|
$
|
1,010
|
||||||||
|
Research and development
|
2,605
|
1,280
|
4,987
|
2,485
|
||||||||||||
|
Selling and marketing
|
2,094
|
1,204
|
4,298
|
2,234
|
||||||||||||
|
General and administrative
|
1,461
|
1,033
|
2,800
|
1,917
|
||||||||||||
|
Total stock-based compensation expense
|
$
|
7,128
|
$
|
4,034
|
$
|
13,977
|
$
|
7,646
|
||||||||
| NOTE 7:- |
BASIC AND DILUTED NET EARNINGS PER SHARE
|
| NOTE 7:- |
BASIC AND DILUTED NET EARNINGS PER SHARE (Cont.)
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
(unaudited)
|
(unaudited)
|
|||||||||||||||
|
Numerator:
|
||||||||||||||||
|
Net income
|
$
|
34,568
|
$
|
22,524
|
$
|
70,254
|
$
|
36,699
|
||||||||
|
Denominator:
|
||||||||||||||||
|
Shares used in computing net earnings per share of common stock, basic
|
45,216,253
|
41,700,399
|
44,726,382
|
41,525,285
|
||||||||||||
|
Effect of stock-based awards
|
3,075,027
|
3,131,191
|
3,258,435
|
2,810,236
|
||||||||||||
|
Shares used in computing net earnings per share of common stock, diluted
|
48,291,280
|
44,831,590
|
47,984,817
|
44,335,521
|
||||||||||||
|
Basic net income per share
|
$
|
0.76
|
$
|
0.54
|
$
|
1.57
|
$
|
0.88
|
||||||||
|
Diluted net income per share
|
$
|
0.72
|
$
|
0.50
|
$
|
1.46
|
$
|
0.83
|
||||||||
| a. |
Taxes on income (tax benefit) are comprised as follows:
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
(unaudited)
|
(unaudited)
|
|||||||||||||||
|
Current year taxes
|
$
|
5,314
|
$
|
959
|
$
|
12,297
|
$
|
2,028
|
||||||||
|
Deferred tax income net, and others
|
(1,697
|
)
|
(773
|
)
|
(3,018
|
)
|
(2,603
|
)
|
||||||||
|
Taxes on income (tax benefit)
|
$
|
3,617
|
$
|
186
|
$
|
9,279
|
$
|
(575
|
)
|
|||||||
| b. |
Deferred income taxes:
|
|
June 30,
|
December 31,
|
|||||||
|
2018
|
2017
|
|||||||
|
(Unaudited)
|
||||||||
|
Net assets in respect of:
|
||||||||
|
Research and Development carryforward expenses- temporary differences
|
$
|
7,229
|
$
|
5,380
|
||||
|
Stock based compensation
|
2,093
|
1,622
|
||||||
|
Allowances, provisions and others
|
2,229
|
1,338
|
||||||
|
Net deferred tax assets
|
$
|
11,551
|
$
|
8,340
|
||||
| c. |
Uncertain tax positions:
|
| d. |
On December 22, 2017, the Tax Cuts and Jobs Act (the "TCJA") was signed into law making significant changes to U.S. income tax law. These changes include, but are not limited to, a corporate tax rate decrease from 35% to 21% effective for tax years beginning after December 31, 2017, the transition of U.S. international taxation from a worldwide tax system to a territorial system, and a one-time transition tax on the mandatory deemed repatriation of cumulative foreign earnings (the “E&P”) as of December 31, 2017.
|
| NOTE 9:- |
CONCENTRATION OF CREDIT RISK AND MAJOR CUSTOMERS
|
| a. |
For the three month period ended June 30, 2018 (unaudited) and 2017 (unaudited), the Company had one major customer that accounted for 16.25% and 13.31% of its consolidated revenues, respectively.
|
| b. |
As of June 30, 2018 (unaudited),
one major customer accounted for
approximately 18.3% of the Company’s net accounts receivable and as
of December
31,
2017, two major customers accounted for approximately 35.2% of the Company’s net accounts receivable.
|
| · |
future demand for solar energy solutions;
|
| · |
changes to net metering policies or the reduction, elimination or expiration of government subsidies and economic incentives for on‑grid solar electricity applications;
|
| · |
changes in the U.S. trade environment, including the recent imposition of import tariffs;
|
| · |
federal, state and local regulations governing the electric utility industry with respect to solar energy;
|
| · |
the retail price of electricity derived from the utility grid or alternative energy sources;
|
| · |
interest rates and supply of capital in the global financial markets in general and in the solar market specifically;
|
| · |
competition, including introductions of power optimizer, inverter and solar photovoltaic (“PV”) system monitoring products by our competitors;
|
| · |
developments in alternative technologies or improvements in distributed solar energy generation;
|
| · |
historic cyclicality of the solar industry and periodic downturns;
|
| · |
defects or performance problems in our products;
|
| · |
our ability to forecast demand for our products accurately and to match production with demand;
|
| · |
our dependence on ocean transportation to deliver our products in a cost effective manner;
|
| · |
our dependence upon a small number of outside contract manufacturers;
|
| · |
capacity constraints, delivery schedules, manufacturing yields and costs of our contract manufacturers and availability of components;
|
| · |
delays, disruptions and quality control problems in manufacturing;
|
| · |
shortages, delays, price changes or cessation of operations or production affecting our suppliers of key components;
|
| · |
business practices and regulatory compliance of our raw material suppliers;
|
| · |
performance of distributors and large installers in selling our products;
|
| · |
our customer’s financial stability, creditworthiness and debt leverage ratio;
|
| · |
our ability to retain key personnel and attract additional qualified personnel;
|
| · |
our ability to effectively design, launch, market and sell new generations of our products and services;
|
| · |
our ability to maintain our brand and to protect and defend our intellectual property;
|
| · |
our ability to retain, and events affecting, our major customers;
|
| · |
our ability to manage effectively the growth of our organization and expansion into new markets;
|
| · |
fluctuations in currency exchange rates;
|
| · |
unrest, terrorism or armed conflict in Israel;
|
| · |
general economic conditions in our domestic and international markets;
|
| · |
consolidation in the solar industry among our customers and distributors; and
|
| · |
the other factors set forth under “Item 1A. Risk Factors” in “Part II-OTHER INFORMATION” section of this report.
|
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||
|
2018
|
2017
|
2018
|
201
7
|
|||||||||||||
|
Inverters shipped
|
113,767
|
75,020
|
213,413
|
132,781
|
||||||||||||
|
Power optimizers shipped
|
2,737,524
|
1,774,480
|
5,213,068
|
3,244,157
|
||||||||||||
|
Megawatts shipped (1)
|
985
|
563
|
1,785
|
1,018
|
||||||||||||
| (1) |
Calculated based on the aggregate nameplate capacity of inverters shipped during the applicable period. Nameplate capacity is the maximum rated power output capacity of an inverter as specified by the manufacturer.
|
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
(In thousands)
|
(In thousands)
|
|||||||||||||||
|
Revenues
|
$
|
227,118
|
$
|
136,099
|
$
|
436,989
|
$
|
251,153
|
||||||||
|
Cost of revenues
|
145,172
|
89,033
|
275,446
|
165,411
|
||||||||||||
|
Gross profit
|
81,946
|
47,066
|
161,543
|
85,742
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
19,551
|
12,725
|
37,426
|
24,183
|
||||||||||||
|
Sales and marketing
|
15,954
|
11,961
|
32,159
|
22,736
|
||||||||||||
|
General and administrative
|
5,776
|
3,265
|
10,465
|
7,704
|
||||||||||||
|
Total operating expenses
|
41,281
|
27,951
|
80,050
|
54,623
|
||||||||||||
|
Operating income
|
40,665
|
19,115
|
81,493
|
31,119
|
||||||||||||
|
Financial income (expenses), net
|
(2,480
|
)
|
3,595
|
(1,896
|
)
|
5,005
|
||||||||||
|
Other expenses
|
-
|
-
|
64
|
-
|
||||||||||||
|
Income before taxes on income
|
38,185
|
22,710
|
79,533
|
36,124
|
||||||||||||
|
Taxes on income (tax benefit)
|
3,617
|
186
|
9,279
|
(575
|
)
|
|||||||||||
|
Net income
|
$
|
34,568
|
$
|
22,524
|
$
|
70,254
|
$
|
36,699
|
||||||||
|
Three Months Ended
June 30,
|
Three Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Revenues
|
$
|
227,118
|
$
|
136,099
|
$
|
91,019
|
66.9
|
%
|
||||||||
| · |
change in the mix of products towards higher portion of commercial products that are characterized with lower ASP per Watt in comparison to residential products;
|
| · |
price declines of our commercial products initiated by the compamy in order to increase market share in this segment;
|
| · |
the introduction of new commercial products with higher capacity which represent further lower ASP per watt;
|
| · |
weaker Euro against the US Dollar which is translated to lower USD ASP combined with growing proportion of our Euro denominated revenues; and
|
| · |
selective price decreases of our residential products.
|
|
Three Months Ended
June 30,
|
Three Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Cost of revenues
|
$
|
145,172
|
$
|
89,033
|
$
|
56,139
|
63.1
|
%
|
||||||||
|
Gross profit
|
$
|
81,946
|
$
|
47,066
|
$
|
34,880
|
74.1
|
%
|
||||||||
| · |
an increase in the volume of products sold;
|
| · |
increased warranty expenses and warranty accruals of $6.9 million associated primarily with the rapid increase in our install base;
|
| · |
increased shipment and logistical costs of $4.5 million attributed, in part, to the growth in volumes shipped, and to an increase in air shipments caused by power component shortages; and
|
| · |
increased personnel-related costs of $2.7 million related to the expansion of our operations and support headcount which is growing in parallel to our growing install base worldwide.
|
| · |
reductions in per-unit production costs
that exceeded price erosion of our products;
|
| · |
increased efficiency in our supply chain; and
|
| · |
general economies of scale in our personnel-related costs and other costs associated with our support and operations departments.
|
|
Three Months Ended
June 30,
|
Three Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Research and development
|
$
|
19,551
|
$
|
12,725
|
$
|
6,826
|
53.6
|
%
|
||||||||
| · |
an increase in personnel-related costs of $5.6 million resulting from an increase in our research and development headcount as well as salary expenses associated with employee equity compensation, resulting from the impact of the increase in our stock price affecting the fair value of any share award. The increase in headcount reflects our continuing investment in enhancements of existing products as well as development associated with bringing new products to market;
|
| · |
expenses related to other directly related overhead costs and travel that increased by $0.5 million;
|
| · |
expenses related to materials consumption that increased by $0.3 million;
|
| · |
depreciation expenses related to lab equipment that increased by $0.3 million; and
|
| · |
expenses related to consultants and sub‑contractors that increased by $0.1 million.
|
|
Three Months Ended
June 30,
|
Three Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Sales and marketing
|
$
|
15,954
|
$
|
11,961
|
$
|
3,993
|
33.4
|
%
|
||||||||
| · |
an increase in personnel-related costs of $3.3 million as a result of an increase in headcount supporting our growth in the U.S., Europe, and the rest of the world, as well as salary expenses associated with employee equity compensation resulting from the impact of the increase in our stock price affecting the fair value of any share award;
|
| · |
expenses related to other sales and marketing activity that increased by $0.3 million;
|
| · |
expenses related to other overhead costs and travel that increased by $0.2 million;
|
| · |
depreciation expenses increased by $0.1 million; and
|
| · |
expenses related to external consultants and sub-contractors increased by $0.1 million.
|
|
Three Months
Ended
June 30,
|
Three Months
Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
General and administrative
|
$
|
5,776
|
$
|
3,265
|
$
|
2,511
|
76.9
|
%
|
||||||||
| · |
expenses related to external consultants and sub-contractors increased by $1.1 million,
partially due to legal proceedings initiated by us during the second quarter of 2018
;
|
| · |
an increase in personnel-related costs of $0.5 million related to (i) higher headcount in the legal, finance, human resources, and information technology department, principally as a result of our continued growthand (ii) changes in management compensation and increased expenses related to equity-based compensation, resulting from the impact of the increase in our stock price affecting the fair value of any share award;
|
| · |
an increase in costs related to the accrual of doubtful & bad debts of $0.4 million; and
|
| · |
other overhead costs, depriciation, and travel expenses, all of which combined increased by $0.5 million.
|
|
Three Months Ended
June 30,
|
Three Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Financial income (expenses), net
|
$
|
(2,480
|
)
|
$
|
3,595
|
$
|
(6,075
|
)
|
N/A
|
|||||||
| · |
an increase of $8.6 million in foreign exchange fluctuations between the Euro and the New Israeli Shekel against the U.S. Dollar;
|
| · |
an increase of $0.6 million in interest expenses related to advance payments received for performance obligations that extend for a period greater than one year, as part of the new revenue recognition standard adoption; and
|
| · |
an increase of $0.1 million in other financial income and bank charges.
|
| · |
a decrease of $2.7 million in costs related to hedging transactions; and
|
| · |
an increase of $0.5 million in interest income and
accretion (amortization) of discount (premium) on marketable securities.
|
|
Three Months Ended
June 30,
|
Three Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Taxes on income
|
$
|
3,617
|
$
|
186
|
$
|
3,431
|
1,884.6
|
%
|
||||||||
| · |
a provision of $2.4 million for Global Intangible Low Taxed Income (“GILTI”); and
|
| · |
an increase of $1.9 million in current tax expenses in Israel triggered by the termination of the two year tax exemption in Israel which ends in 2018.
|
|
Three Months Ended
June 30,
|
Three Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(in thousands)
|
||||||||||||||||
|
Net income
|
$
|
34,568
|
$
|
22,524
|
$
|
12,044
|
53.5
|
%
|
||||||||
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Revenues
|
$
|
436,989
|
$
|
251,153
|
$
|
185,836
|
74.0
|
%
|
||||||||
| · |
change in the mix of products towards higher portion of commercial products that are characterized with lower ASP per Watt in comparison to residential product;
|
| · |
price declines of our commercial products initiated by the compamy in order to increase market share in this segment;
|
| · |
the introduction of new commercial products with higher capacity which represent further lower ASP per watt;
|
| · |
weaker Euro against the US Dollar which is translated to lower USD ASP combined with growing proportion of our Euro denominated revenues; and
|
| · |
selective price decreases of our residential products.
|
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Cost of revenues
|
$
|
275,446
|
$
|
165,411
|
$
|
110,035
|
66.5
|
%
|
||||||||
|
Gross profit
|
$
|
161,543
|
$
|
85,742
|
$
|
75,801
|
88.4
|
%
|
||||||||
| · |
an increase in the volume of products sold;
|
| · |
increased warranty expenses and warranty accruals of $14.6 million associated primarily with the rapid increase in our install base;
|
| · |
increased shipment and logistical costs of $10.7 million attributed, in part, to the growth in volumes shipped, and to an increase in air shipments caused by power component shortages; and
|
| · |
increased personnel-related costs of $5.8 million related to the expansion of our operations and support headcount which is growing in parallel to our growing install base worldwide.
|
| · |
reductions in per-unit production costs
that exceeded price erosion of our products;
|
| · |
increased efficiency in our supply chain; and
|
| · |
general economies of scale in our personnel-related costs and other costs associated with our support and operations departments.
|
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Research and development
|
$
|
37,426
|
$
|
24,183
|
$
|
13,243
|
54.8
|
%
|
||||||||
| · |
an increase in personnel-related costs of $10.9 million resulting from an increase in our research and development headcount as well as salary expenses associated with employee equity compensation, resulting from the impact of the increase in our stock price affecting the fair value of any share award. The increase in headcount reflects our continuing investment in enhancements of existing products as well as development associated with bringing new products to market;
|
| · |
expenses related to other directly related overhead costs and travel expenses that increased by $0.9 million;
|
| · |
depreciation expenses related to lab equipment that increased by $0.6 million;
|
| · |
expenses related to consultants and sub‑contractors that increased by $0.5 million; and
|
| · |
expenses related to materials consumption increased by $0.3 million.
|
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Sales and marketing
|
$
|
32,159
|
$
|
22,736
|
$
|
9,423
|
41.4
|
%
|
||||||||
| · |
an increase in personnel-related costs of $7.8 million as a result of an increase in headcount supporting our growth in the U.S., Europe, and the rest of the world, as well as salary expenses associated with employee equity compensation resulting from the impact of the increase in our stock price affecting the fair value of any share award;
|
| · |
expenses related to other overhead costs and travel expenses that increased by $0.7 million;
|
| · |
expenses related to other sales and marketing activity that increased by $0.6 million; and
|
| · |
expenses related to external consultants and sub-contractors and depreciation expenses increased by $0.3 million.
|
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
General and administrative
|
$
|
10,465
|
$
|
7,704
|
$
|
2,761
|
35.8
|
%
|
||||||||
| · |
an increase in personnel-related costs of $1.9 million related to (i) higher headcount in the legal, finance, human resources, and information technology department, functions required of a fast-growing public company and (ii) changes in management compensation and increased expenses related to equity-based compensation, resulting from the impact of the increase in our stock price affecting the fair value of any share award;
|
| · |
expenses related to external consultants and sub-contractors expenses increased by $1.0 million, partially due to legal proceedings initiated by us during the second quarter of 2018;
|
| · |
expenses related to other overhead costs which increased by $0.4 million; and
|
| · |
expenses related to depriciation and travel which increased by $0.4 million.
|
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Financial income (expenses), net
|
$
|
(1,896
|
)
|
$
|
5,005
|
$
|
(6,901
|
)
|
N/A
|
|||||||
| · |
an increase of $7.8 million in foreign exchange fluctuations between the Euro and the New Israeli Shekel against the U.S. Dollar;
|
| · |
an increase of $1.0 million in interest expenses related to advance payments received for performance obligations that extend for a period greater than one year, as part of the new revenue recognition standard adoption; and
|
| · |
an increase of $0.2 million in other financial expenses and bank charges .
|
| · |
a decrease of $1.3 million in costs related to hedging transactions; and
|
| · |
an increase of $0.8 million in interest income and
accretion (amortization) of discount (premium) on marketable securities.
|
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Taxes on income (tax benefit)
|
$
|
9,279
|
$
|
(575
|
)
|
$
|
9,854
|
N/A
|
||||||||
| · |
an increase of $5.2 million in current tax expenses in Israel triggered by the termination of the two year tax exemption in Israel which ends in 2018;
|
| · |
a provision of $4.0 million for Global Intangible Low Taxed Income (“GILTI”) and an adjustment of $0.8 million related to transition tax on the mandatory deemed repatriation of cumulative foreign earnings under the U.S. Tax Cuts and Jobs Act of 2017;
|
| · |
an increase of $0.3 million in current tax expenses in other jurisdictions; and
|
| · |
a tax income related to the previous year’s tax credit of $0.5 million which was recorded in the six months ended June 30, 2017.
|
|
Six Months Ended
June 30,
|
Six Months Ended
June 30,
2017 to 2018
|
|||||||||||||||
|
2018
|
2017
|
Change
|
||||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Net income
|
$
|
70,254
|
$
|
36,699
|
$
|
33,555
|
91.4
|
%
|
||||||||
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|||||||||||||||
|
2018
|
2017
|
2018
|
2017
|
|||||||||||||
|
(In thousands)
|
||||||||||||||||
|
Net cash provided by operating activities
|
$
|
43,891
|
$
|
31,563
|
$
|
107,870
|
$
|
57,163
|
||||||||
|
Net cash used in investing activities
|
(61,688
|
)
|
(39,766
|
)
|
(63,949
|
)
|
(50,043
|
)
|
||||||||
|
Net cash provided by financing activities
|
2,986
|
1,752
|
7,591
|
2,123
|
||||||||||||
|
Increase (decrease) in cash, cash equivalents and restricted cash
|
$
|
(14,811
|
)
|
$
|
(6,451
|
)
|
$
|
51,512
|
$
|
9,243
|
||||||
|
Exhibit
No.
|
Description
|
Incorporation by Reference
(where a report is indicated below, that
document has been previously filed with
the SEC and the applicable exhibit is
incorporated by reference thereto)
|
|
|
Filed with this report.
|
|||
|
Filed with this report.
|
|||
|
Filed with this report.
|
|||
|
Filed with this report.
|
|||
|
101.INS
|
XBRL Instance Document
|
Filed with this report.
|
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
Filed with this report.
|
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
Filed with this report.
|
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
Filed with this report.
|
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
Filed with this report.
|
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
Filed with this report.
|
|
Date: August 3, 2018
|
SOLAREDGE TECHNOLOGIES, INC.
/s/ Guy Sella
|
|
|
Guy Sella
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
|
||
|
Date: August 3, 2018
|
/s/ Ronen Faier
|
|
|
Ronen Faier
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|